Publications by authors named "J Zander"

Article Synopsis
  • Angiotensin II (Ang-II) is crucial in causing microcirculatory dysfunction, especially in patients with sepsis and acute kidney injury, leading to uncertainty about factors affecting its concentration in the early sepsis phase.
  • A study measured Ang-II levels in 171 sepsis patients post-antibiotic treatment using various statistical methods to identify correlations with clinical factors.
  • Results showed a high median Ang-II concentration, with significant correlations found including kidney replacement therapy and fluid balance, indicating sick patients with kidney treatment had notably higher Ang-II levels compared to those on ECMO.
View Article and Find Full Text PDF

For a carbon-neutral society, the production of hydrogen as a clean fuel through water electrolysis is currently of great interest. Since water electrolysis is a laborious energetic reaction, it requires high energy to maintain efficient and sustainable production of hydrogen. Catalytic electrodes can reduce the required energy and minimize production costs.

View Article and Find Full Text PDF

Lasers for generating monochromatic light beams with sideband spectra in strongly squeezed vacuum states are the basis for aspired optical continuous-variable quantum computers. We have developed a "squeeze laser" that produces 10 dB squeezed vacuum states at a wavelength of 1550 nm, the latter being tunable by 0.5 nm without losing the high squeeze factor.

View Article and Find Full Text PDF

Purpose: Inadequate piperacillin (PIP) exposure in intensive care unit (ICU) patients threatens therapeutic success. Model-informed precision dosing (MIPD) might be promising to individualize dosing; however, the transferability of published models to external populations is uncertain. This study aimed to externally evaluate the available PIP population pharmacokinetic (PopPK) models.

View Article and Find Full Text PDF

Cefepime has been reported to cause concentration-related neurotoxicity, especially in critically ill patients with renal failure. This evaluation aimed to identify a dosing regimen providing a sufficient probability of target attainment (PTA) and the lowest justifiable risk of neurotoxicity in critically ill patients. A population pharmacokinetic model was developed based on plasma concentrations over four consecutive days obtained from 14 intensive care unit (ICU) patients.

View Article and Find Full Text PDF